UPMC Mercy Hospital
Pittsburgh, Pennsylvania, 15221, United States
NCT Number: NCT01548183
The US preventative services task force (USPSTF) recommends behavioral counseling in the primary care setting for prevention of sexually transmitted diseases, however, screening and counseling rarely occur. Text messaging (TM) is increasingly being used as a tool to affect behavior change in patients, but its effect on patients that report at-risk sexual behavior in the emergency department (ED) is unknown. The investigators seek to assess the feasibility of ED-based screening of young adult females for at-risk sexual behavior and enrolling them in a 3 month trial using TM to deliver information and skill building to improve health behavior.
Looking for future studies?
Notify Me18 year–25 year
Female
Interventional
Phase 2
Pittsburgh, Pennsylvania, 15221, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Weekly SMS assessments of risky sexual encounters with feedback
Time frame: 3 months after ED discharge
Participants will be called for phone follow-up at 12 weeks post-ED discarge
Time frame: 3 months post-ED discharge
Participants will be called for phone follow-up at 12 weeks post ED discharge
University of Pittsburgh
Other
Mobile Phone Text-message Program to Reduce Risky Sexual Behavior in Young Females Discharged From the Emergency Department
Acronym: StARSS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05664802
Acquired Immunodeficiency Syndrome, Behavior
Flagstaff, Arizona, United States
View Trial DetailsNCT05120869
Behavior, COVID-19
Las Cruces, New Mexico, United States
View Trial DetailsNCT06098690
Adherence, Patient, Behavior
El Paso, Texas, United States
View Trial DetailsNCT05242952
Behavior, Blood-Borne Infections
Orange, Connecticut, United States
View Trial Details